test
test
test
test

RxBN & Company

We Care For You Health

We bring unique expertise in innovation, cost effectiveness,
organizational design, and other disciplines that determine which
pharma/biotech companies achieve the peak of industry leadership.
Contrary to popular belief, Lorem Ipsum is not simply
random text. It has roots in a piece of classical
Latin literature
See All Services   See All Services  
test
test
test
test

RxBN & Company

We Care For You Health

We bring unique expertise in innovation, cost effectiveness,
organizational design, and other disciplines that determine which
pharma/biotech companies achieve the peak of industry leadership.
Contrary to popular belief, Lorem Ipsum is not simply
random text. It has roots in a piece of classical
Latin literature
See All Services   See All Services  
test
test
test
We Care For You Health

RxBN & Company

RxBN & Company

We bring unique expertise in innovation, cost effectiveness,
organizational design, and other disciplines that determine which
pharma/biotech companies achieve the peak of industry leadership.
Contrary to popular belief, Lorem Ipsum is not simply
random text. It has roots in a piece of classical
Latin literature
See All Services   See All Services  
bio-rxbn-1

Welcome To
RxBN & Company

RxBN was founded on the principles of quality, innovation, Disruption and collaboration. We believe these principles yield great experiences, right decision-making, and better businesses outcomes. We bring unique expertise in innovation, cost effectiveness, organizational design, and other disciplines that determine which pharma/biotech companies achieve the peak of industry leadership. RxBN helps pharmaceutical/biotechnology manufacturers become more competitive in a rapidly evolving market characterized by unpredictable product and uncertain regulatory actions.

Our Services

What we do

RxBN helps biotech companies to build robust strategies. We works with small and medium scale pharmaceutical, biotech companies and startups for creating the foundations for their future growth and improve effectiveness of their current business operations. The company’s diverse area include asset management, franchise and corporate-level strategies development at different levels and stages. Our engagement with any project begin with a clear understanding of your desired goal. We deploy the fit-for-purpose analytical approach since the technological advancements have been taking inroads into the development, testing phases of various new drugs, disrupting the processes to unfold innovations to create new opportunities and an evolved business model. Through our diverse engagement and experiences with different companies, we understand that the product development cycle for the Pharma/biotech sector is a long term process. It is thus highly desirable for our clients to find trustworthy talent who have the ability to dedicatedly give 100% of team time to your project with a leadership team to bring innovation and disruption in the long run. We are committed to provide time bound and high-quality value-added disruptive solutions for a wide range of operational and management roles.
  • We live and innovate with Biotechnology/pharmaceutical industry
We solve fundamental problem of any organization in a rapidly growing competitive market by utilizing knowledge of diverse expertise of different sections for an organization. Our team works 24×7 to enable integration and communication of desired endeavors of the organization.
  • We challenge the status quo
As per survey and statistics almost 72 percent of leaders say they never or rarely challenge their status quo, nor do they encourage employees to think outside the box. We as a company re-enforce learning, collaboration, team building and diverse cross cultural exchange of ideas and knowledge to come up with unique, innovative and most robust solution to any problem. We put dedicated team of desired expertise to solve complex problem using smart, intellectually curious team members.
  • We create culture of innovation
Success is a journey. We create a culture of working at each individual step of any process to cultivate and bring ultimate path breaking disruptive solutions to organization. We make feel our customer that their every individual steps and employee matter by fostering a culture of creative, critical, out of the box thinking approach for a problem. We encourage team building and provide them freedom to come up with their own solutions and integrate them with other members of team. That is how we provide them with disruptive, innovative and path breaking solution.
  • We believe in collaboration
We solve complex problems with the integration of simple solutions with transparent, collaborative and creative approaches. We provide innovative, crisp and concise recommendations to our business clients. We encourage and help our business clients to become the future market leaders by focusing on the priorities to make them agile and adaptable to attractive market opportunities, including:
  • Cost-Effective Business Models.Pharma and Biotech companies require to adopt their business models to increase their revenue on sales. A radical redesign of all processes with a zero-based budgeting approach can help change preconceived notions of how things have been done before.
  • Expanding businesses beyond the A general trend in slowing down of growth in core oriented companies has led, pharma companies more tempted to consider adjacent markets for growth. Leading players will identify and develop their internal hidden assets where they can innovate, exchange ideas and knowledge at every level of organization and share customers a story of cost effective management or develop overlapping capabilities.
  • Engaging benefits of global scale with internal complexityIndustry consolidations and collaborations at the international level with various market research strategies has created a massive scale across the value chain. Successful pharma and biotech companies may dominate and discriminate with surplus advantages of extra resources and global scale. Hence to make small and medium scale companies to innovate and disrupt at every level of organization with our unique strategies developed and created for company in question.
  • Embracing the culture of innovation and To realize the full potential of their R&D capabilities Pharma and Biotech companies can embrace the potential to develop a culture that encourages the scientific endeavor to be innovative and creative by building portfolios that balance investments in riskier product development and source innovation from both internal and collaborative efforts.
  • Post-Merger Advice Life sciences companies dodge with the difficult situations that eliminate the chances of acquisition by adapting to the integrate the assertion to the deal assertion, integrating in essential platforms, acting quickly to create value for shareholders and setting a high-growth trajectory.
  • We invest in people
The difference between a successful company and a company trying achieve a scale where a successful company has been is a matter of culture created for the people in the organization. We provide best training and foster value of human relations in terms of soft skills with the creation of diverse team and cross cultural platform.

Our Team

Get in touch with us for free consultation!

15

Years of Experience

390

Procurement

559

Sustainability

6930

Happy People

Articles

Our Latest News

Digital transformation of healthcare in India

The year of 2019 has already penetrated by the artificial intelligence and other digital tools in various fields of technology including…

Punjab and Cancer

Punjab is primarily an agricultural state of India and it used to enjoy the benefits of fertile lands and abundance of…

Our Perspective

Over the last three decades, the global agenda of pharmaceutical & Biotechnology industry has made a revolutionary contributions for advanced and compassionate patient care. The sector now faces the challenges of unpredictable product pipelines, ultra high competitive markets, unpredictable policies and regulatory conditions. Despite ongoing medical needs and related technologies for diverse category of diseases, pharmaceutical & Biotechnology companies much like medical device companies not only explore and depend upon innovations & creativities as a fuel engine but also do a favor to enhance pricing power to achieve profitable growth using diverse set of strategies.

The net result of increasing pressure of cost effectiveness and a continuous decline in R&D productivity will be an example of immense decline in the share of the overall profit margin gained by the largest research-based pharmaceutical/biotechnology companies, while lower-margin sectors, like generic manufacturers, will increase their share. The important and fundamental question for these companies is how to evolve their business model in order to flourish in an ultra-competitive market only profit oriented world by focusing on results and achieving targets with the adoption cost effectiveness criteria.

Pharmaceuticals Insights

Good brands and promising consumer health care companies have insights that buyers generally countermand brands often. So to grow businesses and brand revenues, they seek to target societies with different socioeconomic background to enhance the sale of their product instead of convincing existing customers or penetrating already existing market to buy more of their product or just raising prices. They constantly motivate their already existing market & customers by continually investing in brand awareness and marketing strategies through innovative ideas, perfect store execution and online sales.
RxBN & Company’s insight in multiple sections of pharma/biotech products has led to the conclusion that when a physician prescribe a drug, the efficacy, safety and adverse effects associated with the profile of drug account for only 50% to 60% of the physician’s choice—and that figure has declined over a time period due to advancement and evolution of new health care products and new categories of drugs. The other 40% to 50% is based on a range of physician and patient experience factors which potential companies target to innovate to distinguished their product categories. As per the data and statistics of the past three years, only 8% of pharma/biotech executives agreed that apart from innovation in product development the innovation in the services, database of information and customer experience around the product is also crucial for their success. That number jumps almost fourfold, to 28%, when executives look ahead to the next three years. The product matters, but their services and customer experiences are getting increasingly important.
In a recent RxBN survey the inclusion of information technology (IT) at every level and aspects of health care products development and marketing innovation are constantly getting adopted with a use of Big Data and Analytics, Cybersecurity and Cloud Services. Approximate 61% of pharma/biotech executives have said that in the next couple of years the big data and analytics will going to reinforce a major contribution for industry. This will transform as many areas as possible while predictive analytics will have a big impact on diagnoses and supply chain management. Cybersecurity technologies and cloud services will remain critical as pharma/biotech companies attempt to protect sensitive health care data and information.